Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1974 3
1976 1
1977 3
1978 4
1979 2
1980 1
1984 2
1986 1
1988 3
1989 3
1990 2
1991 1
1992 2
1995 1
2000 1
2003 1
2006 1
2007 2
2008 2
2009 3
2010 1
2011 1
2012 1
2013 3
2014 4
2015 2
2019 1
2020 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
Neuro-ophthalmology.
Agnetti V. Agnetti V. Curr Opin Neurol Neurosurg. 1991 Oct;4(5):783-7. Curr Opin Neurol Neurosurg. 1991. PMID: 10148443 Review.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictors.
Leonetti A, Peroni M, Agnetti V, Pratticò F, Manini M, Acunzo A, Marverti F, Sulas S, Rapacchi E, Mazzaschi G, Perrone F, Bordi P, Buti S, Tiseo M. Leonetti A, et al. Among authors: agnetti v. BMJ Support Palliat Care. 2023 Sep 4:spcare-2023-004558. doi: 10.1136/spcare-2023-004558. Online ahead of print. BMJ Support Palliat Care. 2023. PMID: 37666650
The PRIAMO study: background, methods and recruitment.
Antonini A, Colosimo C, Marconi R, Morgante L, Barone P; PRIAMO study group. Antonini A, et al. Neurol Sci. 2008 Apr;29(2):61-5. doi: 10.1007/s10072-008-0863-z. Epub 2008 May 16. Neurol Sci. 2008. PMID: 18483702
POEMS syndrome: a case report.
Bisail M, Cossu A, Massarelli G, Tanda F, Agnetti V, Traccis S, Cassisa L, Puliga MV, Bartoli E. Bisail M, et al. Among authors: agnetti v. Haematologica. 1990 Jul-Aug;75(4):384-6. Haematologica. 1990. PMID: 2276681
51 results